Palatin Technologies Inc (PTN): Revenue

Annual figures by period end, from SEC filings.

$13.19M
Year ended 2026-06-30
$4.70M
Trailing 12 months to 2026-09-30
Period endedRevenueChange YoYSource filing
2026-06-30$13.19Mn/a2026-09-28, From 2025-07-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Palatin Technologies Inc (PTN)2026-06-30$13.19Mn/a
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.11M+29.8%
Evommune, Inc. (EVMN)2025-12-31$13.00M+85.7%
CV Sciences, Inc. (CVSI)2025-12-31$13.79M-12.2%
Pyxis Oncology, Inc. (PYXS)2025-12-31$13.86M-14.2%
Emmaus Life Sciences, Inc. (EMMA)2025-12-31$12.45M-25.2%
Arbutus Biopharma Corp (ABUS)2025-12-31$14.08M+128.2%
Opus Genetics, Inc. (IRD)2025-12-31$14.20M+29.1%
Prelude Therapeutics Inc (PRLD)2025-12-31$12.14M+73.4%

Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗